A potential peptide derived from cytokine receptors can bind proinflammatory cytokines as a therapeutic strategy for anti-inflammation SJ Jiang, PI Tsai, SY Peng, CC Chang, Y Chung, HH Tsao, HT Huang, ... Scientific reports 9 (1), 2317, 2019 | 26 | 2019 |
Peptides derived from CXCL8 based on in silico analysis inhibit CXCL8 interactions with its receptor CXCR1 SJ Jiang, JW Liou, CC Chang, Y Chung, LF Lin, HJ Hsu Scientific reports 5 (1), 18638, 2015 | 25 | 2015 |
Internal water channel formation in CXCR4 is crucial for Gi-protein coupling upon activation by CXCL12 CC Chang, JW Liou, KTP Dass, YT Li, SJ Jiang, SF Pan, YC Yeh, HJ Hsu Communications Chemistry 3 (1), 133, 2020 | 19 | 2020 |
A Sequence in the loop domain of hepatitis C virus E2 protein identified in silico as crucial for the selective binding to human CD81 CC Chang, HJ Hsu, JH Yen, SY Lo, JW Liou PloS one 12 (5), e0177383, 2017 | 15 | 2017 |
Hepatitis C virus core protein: Not just a nucleocapsid building block, but an immunity and inflammation modulator H Mani, JH Yen, HJ Hsu, CC Chang, JW Liou Tzu Chi Medical Journal 34 (2), 139-147, 2022 | 6 | 2022 |
Computer-aided discovery, design, and investigation of COVID-19 therapeutics CC Chang, HJ Hsu, TY Wu, JW Liou Tzu Chi Medical Journal 34 (3), 276-286, 2022 | 5 | 2022 |
The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma CD Liu, CC Chang, WH Huang Tzu Chi Medical Journal 33 (3), 257-262, 2021 | 4 | 2021 |
Valine-279 Deletion–Mutation on Arginine Vasopressin Receptor 2 Causes Obstruction in G-Protein Binding Site: A Clinical Nephrogenic Diabetes Insipidus Case and Its Sub … MC Chen, YC Hsiao, CC Chang, SF Pan, CW Peng, YT Li, CD Liu, ... Biomedicines 9 (3), 301, 2021 | 2 | 2021 |
Targeting of interleukin-10 receptor by a potential human interleukin-10 peptide efficiently blocks interleukin-10 pathway-dependent cell proliferation CC Chang, CD Liu, SF Pan, WH Huang, CW Peng, HJ Hsu Tzu Chi Medical Journal 32 (3), 245-253, 2020 | 2 | 2020 |
Therapeutic peptide RF16 derived from CXCL8 Inhibits MDA-MB-231 cell invasion and metastasis CM Chang, CC Chang, HYP Lam, SY Peng, YH Lai, BD Hsiang, YY Liao, ... International Journal of Molecular Sciences 24 (18), 14029, 2023 | 1 | 2023 |
In silico study on the internal signal pathway of different mutants of vasopressin receptor 2 with arginine vasopressin bound TY Hu, HJ Hsu, CC Chang Biophysical Journal 122 (3), 198a-199a, 2023 | | 2023 |
A Multitarget Therapeutic Peptide Derived From Cytokine Receptors Based on in Silico Analysis Alleviates Cytokine-Stimulated Inflammation CC Chang, SY Peng, HH Tsao, HT Huang, XY Lai, HJ Hsu, SJ Jiang Frontiers in Pharmacology 13, 853818, 2022 | | 2022 |
Combinatorial Virtual Screening Revealed a Novel Scaffold for TNKS Inhibition to Combat Colorectal Cancer CC Chang, SF Pan, MH Wu, CT Cheng, YR Su, SJ Jiang, HJ Hsu Biomedicines 10 (1), 143, 2022 | | 2022 |
Valine-279 Deletion–Mutation on Arginine Vasopressin Receptor 2 Causes Obstruction in G-Protein Binding Site: A Clinical Nephrogenic Diabetes Insipidus Case and Its Sub … MC Chen, YC Hsiao, CC Chang, SF Pan, CW Peng, YT Li, CD Liu, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | | 2021 |
In silico and in vitro studies on the activation and signaling mechanisms of CXCL12 binding to its cognate receptor CXCR4 CC Chang, KTP Dass, SJ Jiang, HJ Hsu ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 256, 2018 | | 2018 |
In Silico Identification of Binding Sites Responsible for Species Specificity on Human CD81 and Hepatitis C Virus E2 Protein CC Chang, HJ Hsu, JW Liou Biophysical Journal 110 (3), 528a, 2016 | | 2016 |
Peptides Derived from CXCL8 Based on in Silico Analysis Inhibit CXCL8 Interactions with its Receptor CXCR1 CC Chang, SJ Jiang, JW Liou, Y Chung, HJ Hsu Biophysical Journal 110 (3), 543a, 2016 | | 2016 |